Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Effects of Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Senthil Sadhasivam
600 participants
Sep 15, 2018
OBSERVATIONAL
Conditions
Summary
The objective of this study is to better understand the comprehensive integration of both clinical and genetic factors that will help to identify mothers who could be at an increased risk of poor response to opioid substitution and infants at risk of significant neonatal abstinence syndrome (NAS).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Pregnant Mothers must be taking buprenorphine / subutex for opioid use disorder.
Mothers who consent will be given a fetal MRI and after the baby is born, a neonatal MRI.
Throughout the pregnancy, Mothers will be participating in blood collection throughout the study. At enrollment, we will collect DNA, Genetic and PK blood specimens, then throughout the study, we will be collecting random PK samples.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03923374